Skip to main content
Premium Trial:

Request an Annual Quote

Exelixis, IMCB Uncover Genes Involved in Immunity

NEW YORK, Dec. 18 – Exelixis and France’s Institute of Molecular and Cellular Biology have identified genes that play a role in immunity, Exelixis said Tuesday.

The findings, which have been published in the Dec. 18 issue of The Proceedings of the National Academy of Sciences , may have implications for the development of new treatments for asthma and rheumatoid arthritis, Exelixis said.

"Our internal efforts coupled with our collaboration with Dr. Jules Hoffman of the IMCB continue to discover promising candidates which, as they advance further through our pipeline, may lead to more effective approaches for the treatment of human inflammatory diseases," George Scangos, CEO of Exelixis, said in a statement.

Exelixis of South San Francisco, Calif., has the commercial rights to use the targets that were discovered. 

The collaborative effort focused on studying the immune system of Drosophila. The researchers introduced fungal and bacterial pathogens into the fruit fly and then monitored some 14,000 genes for changes in gene expression.

The Scan

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.

Machine Learning Improves Diagnostic Accuracy of Breast Cancer MRI, Study Shows

Combining machine learning with radiologists' interpretations further increased the diagnostic accuracy of MRIs for breast cancer, a Science Translational Medicine paper finds.

Genome Damage in Neurons Triggers Alzheimer's-Linked Inflammation

Neurons harboring increased DNA double-strand breaks activate microglia to lead to neuroinflammation like that seen in Alzheimer's disease, a new Science Advances study finds.

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.